Abstract
Conditions: Multiple Sclerosis; Neuromyelitis Optica Spectrum Disorder; Demyelinating Diseases of the Central Nervous System
Intervention: Drug: Ofatumumab
Sponsor: Tianjin Medical University General Hospital
Not yet recruiting
ID: 198045
Discovery Date: 10 June 2022, 11:50:06 UTC
Published Date: 2022-06-10 16:00:00
Source: Clinical Trials.gov
Link: https://clinicaltrials.gov/ct2/show/NCT05414487?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14